Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
ADN

ADN - Advent Technologies Holdings, Inc. Stock Price, Fair Value and News

0.17USD0.00 (0.00%)Delayed as of 21 Feb 2024, 01:53 pm ET
Watchlist

Market Summary

USD0.170.00
Delayedas of 21 Feb 2024, 01:53 pm
0.00%

ADN Stock Price

View Fullscreen

ADN RSI Chart

ADN Valuation

Market Cap

10.6M

Price/Earnings (Trailing)

-0.11

Price/Sales (Trailing)

2

EV/EBITDA

-0.08

Price/Free Cashflow

-0.95

ADN Price/Sales (Trailing)

ADN Profitability

EBT Margin

-1749.10%

Return on Equity

-286.32%

Return on Assets

-168.4%

Free Cashflow Yield

-104.95%

ADN Fundamentals

ADN Revenue

Revenue (TTM)

5.3M

Rev. Growth (Yr)

-47.31%

Rev. Growth (Qtr)

13.67%

ADN Earnings

Earnings (TTM)

-93.3M

Earnings Growth (Yr)

-3.3%

Earnings Growth (Qtr)

45.74%

Breaking Down ADN Revenue

52 Week Range

0.17
(Low)(High)

Last 30 days

-5.6%

Last 90 days

-66%

Trailing 12 Months

-90.8%

How does ADN drawdown profile look like?

ADN Financial Health

Current Ratio

1.84

ADN Investor Care

Shares Dilution (1Y)

20.91%

Diluted EPS (TTM)

-1.76

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20237.6M6.4M5.3M0
20226.8M8.1M8.8M7.8M
20212.3M3.1M4.5M7.1M
20203.7M2.8M1.8M882.7K
20190004.6M
20180000

Tracking the Latest Insider Buys and Sells of Advent Technologies Holdings, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Sep 06, 2023
gregoriou vassilios
sold
-7,517
0.531
-14,157
ceo, chair
Sep 06, 2023
brackman kevin l.
sold
-14,746
0.531
-27,771
cfo
Feb 08, 2023
gregoriou vassilios
sold
-43,528
1.9179
-22,696
ceo, chair
Feb 08, 2023
de castro emory sayre
sold
-18,093
1.9565
-9,248
cto
Feb 08, 2023
coffey james f.
sold
-17,521
1.9179
-9,136
coo, gc
Feb 07, 2023
gregoriou vassilios
sold
-67,261
1.9588
-34,338
ceo, chair
Feb 07, 2023
de castro emory sayre
sold
-27,407
1.9588
-13,992
cto
Feb 07, 2023
coffey james f.
sold
-27,076
1.9588
-13,823
coo, gc

1–10 of 45

Which funds bought or sold ADN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 15, 2024
BARCLAYS PLC
sold off
-100
-21,000
-
-%
Feb 14, 2024
MILLENNIUM MANAGEMENT LLC
added
131
1,775
7,368
-%
Feb 14, 2024
VANGUARD GROUP INC
unchanged
-
-213,336
282,253
-%
Feb 14, 2024
Royal Bank of Canada
reduced
-53.01
-
-
-%
Feb 14, 2024
CITADEL ADVISORS LLC
new
-
45,954
45,954
-%
Feb 14, 2024
ALLIANCEBERNSTEIN L.P.
added
7.86
-47,420
75,517
-%
Feb 14, 2024
STATE STREET CORP
unchanged
-
-26,137
34,579
-%
Feb 14, 2024
GROUP ONE TRADING, L.P.
reduced
-3.26
-18,880
23,168
-%
Feb 14, 2024
LMR Partners LLP
new
-
86,541
86,541
-%

1–10 of 42

Are Funds Buying or Selling ADN?

Are funds buying ADN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ADN
No. of Funds

Unveiling Advent Technologies Holdings, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 12, 2024
lmr partners llp
4.2%
3,158,425
SC 13G/A
Jan 10, 2024
bnp paribas asset management uk ltd
3.20%
2e+06
SC 13G/A
Oct 03, 2023
bnp paribas asset management uk ltd
4.88%
2,927,358
SC 13G/A
Apr 04, 2023
f.e.r. fischer edelstahlrohre gmbh
0.00%
0
SC 13G/A
Feb 09, 2023
lmr partners llp
2.6%
1,365,598
SC 13G
Feb 08, 2023
invesco ltd.
0.0%
0
SC 13G/A
Jan 31, 2023
bnp paribas asset management uk ltd
10.73%
5,549,573
SC 13G/A
Jul 05, 2022
bnp paribas asset management uk ltd
10.59%
5,464,216
SC 13G/A
Feb 14, 2022
invesco ltd.
5.4%
2,778,867
SC 13G
Feb 09, 2022
fmr llc
-
0
SC 13G/A

Recent SEC filings of Advent Technologies Holdings, Inc.

View All Filings
Date Filed Form Type Document
Feb 20, 2024
4
Insider Trading
Feb 12, 2024
SC 13G/A
Major Ownership Report
Feb 12, 2024
3
Insider Trading
Jan 25, 2024
8-K
Current Report
Jan 17, 2024
8-K/A
Current Report
Jan 11, 2024
8-K
Current Report
Jan 10, 2024
SC 13G/A
Major Ownership Report
Dec 28, 2023
424B5
Prospectus Filed
Dec 27, 2023
8-K
Current Report
Dec 27, 2023
424B5
Prospectus Filed

What is the Fair Value of ADN?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to Advent Technologies Holdings, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
42.5B
19.3B
-0.17% -10.16%
18.83
2.21
2.48% -8.23%
23.6B
4.2B
-7.10% -18.36%
25
5.57
11.66% 15.12%
18.4B
7.9B
-3.31% -18.08%
15.81
2.32
6.33% 11.62%
17.1B
3.9B
-1.59% -1.35%
18.53
4.34
-15.47% 16.09%
12.1B
8.2B
-3.66% -21.21%
22.67
1.48
6.33% -40.31%
11.7B
29.9B
2.33% 48.88%
-6.56
0.39
-2.81% -194.18%
11.0B
12.8B
-9.06% -34.82%
-16.36
0.86
3.51% -218.48%
MID-CAP
7.8B
4.7B
-4.67% -8.33%
15.84
1.66
14.58% -10.43%
3.3B
1.9B
-3.82% -1.80%
13.41
1.74
23.25% 23.96%
2.6B
1.7B
-5.94% -16.01%
15.91
1.53
5.10% 28.81%
SMALL-CAP
1.9T
672.6M
1.66% -14.88%
21.2K
2.8K
2.88% 2.37%
475.1M
155.4M
-8.37% 100.66%
22.27
3.06
88.76% 261.60%
194.8M
1.9M
3.21% -32.00%
-6.18
101.48
79.73% -32.29%
35.1M
456.0M
1.79% 67.96%
5.67
0.08
1.78% 128.25%
12.4M
867.4K
-7.30% -12.23%
-3.22
11.75
-88.45% 73.79%

Advent Technologies Holdings, Inc. News

Latest updates
Investing.com08 Jan 202408:00 am
StockNews.com10 months ago

Advent Technologies Holdings, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue13.7%1,264,0001,112,000977,0001,957,0002,399,0002,225,0001,256,0002,902,0881,674,0001,003,0001,489,000356,620225,412200,354564,191928,0271,179,2531,270,6901,260,391-
Gross Profit-50.3%-1,192,000-793,000-507,000-498,00060,000-45,000-261,000159,00028,000334,0001,142,000217,232134,935-17,56234,229-----
Operating Expenses------------497,828414,612393,205116,92587,621114,179103,370133,84760,860
  S&GA Expenses7.0%8,916,0008,331,0008,489,0009,258,0008,203,0007,956,00010,498,00014,318,00013,041,0006,596,0007,922,0001,905,793886,629444,129310,305--103,370133,847-
  R&D Expenses-26.1%2,131,0002,883,0003,141,0002,458,0002,547,0002,642,0002,149,0001,980,000893,000639,00029,00021,26537,640-43,633-----
EBITDA Margin-23.2%-17.46-14.17-10.73-9.54-4.30-4.60-4.18-2.96-2.94-0.870.07-3.52--------
Interest Expenses-100.0%-8,000110,00061,000-1,000-10,000-24,000-14,000-3,000-10,000-793-1,712-514-2,523-----
Income Taxes-2100.0%-80,0004,000796,000-307,000-567,000-439,000-657,000-872,000-51,000----3,1013,101-639,999199,916-274,139229,000113,000
Earnings Before Taxes45.4%-11,926,000-21,827,000-11,192,000-47,932,000-12,035,000-11,587,000-4,753,000-9,878,000-11,331,000-3,143,0002,906,000-1,703,005-751,917-309,018-357,1021,554,281-345,5511,343,70320,028,620424,415
EBT Margin-21.2%-17.49-14.43-10.95-9.74-4.36-4.66-4.26-3.03-2.93-0.880.06-3.540.070.200.59-----
Net Income45.7%-11,846,000-21,831,000-11,988,000-47,625,000-11,468,000-11,148,000-4,096,000-9,006,000-11,280,000-3,143,0002,906,000-1,703,005-748,816-312,119-357,1021,188,421-545,4671,069,56419,799,620308,815
Net Income Margin-21.9%-17.57-14.42-10.88-9.49-4.07-4.41-4.03-2.90-2.92-0.870.06-3.54-0.13-0.010.37-----
Free Cashflow-Infinity%-8,317,000-------------------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-13.3%55.0064.0081.0090.00127137148163174130137146154153226226225224223222
  Current Assets-25.3%24.0031.0039.0050.0061.0071.0083.0097.001081211322.000.000.000.001.001.001.001.001.00
    Cash Equivalents-63.6%4.0010.0020.0033.0042.0046.0059.0080.0092.001161251.001.001.002.001.001.001.001.001.00
  Inventory-8.2%14.0015.0015.0013.0011.0010.009.007.006.001.001.000.00--------
  Net PPE18.3%24.0021.0020.0018.0010.0010.009.009.008.001.000.000.00--------
  Goodwill---6.006.0030.0030.0030.0030.00------------
Liabilities-4.3%23.0024.0026.0025.0020.0019.0020.0033.0038.0024.0029.004.0032.0025.0015.0019.0020.0018.0018.008.00
  Current Liabilities-4.2%13.0013.0015.0014.0014.0014.0014.0019.0015.004.005.003.002.001.001.001.001.001.001.000.00
Shareholder's Equity-18.7%33.0040.0055.0064.0010711812913013610710911.0011.0010.000.009.005.005.005.005.00
  Retained Earnings-8.4%-153-141-119-107-60.14-48.67-37.52-33.42-24.42-13.14-10.00-12.908.0014.0025.0020.0019.0020.0019.000.00
  Additional Paid-In Capital2.7%18918417717517217016816516112011911.00-3.42-9.19-20.18-15.23-14.05-14.59-13.525.00
Shares Outstanding6.3%62.0058.0052.0052.0051.0051.0051.0051.0048.0046.0038.0025.0023.0019.0015.00-----
Float------99.00---305---153---219-210
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations0.2%-7,439-7,451-11,44841.00-2,810-10,045-19,311-11,147-8,459-4,035-12,196-380-354-349-341-78.90-50.45-350-150-110-3.68
Cashflow From Investing74.0%-919-3,539-1,887-10,532-863-2,112-1,010-1,554-14,602-5,347-4,053-33.38-24.34-30.09-34.7010.00-255--220,520-
Cashflow From Financing-2,078--1.00-41.00--5.00-4.00807140,69319*-25.66-34.33942----221,48438.00
  Buy Backs-------------35.00118-------

ADN Income Statement

2023-09-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Revenue$ 1,264$ 2,399$ 3,353$ 5,880
Cost of revenues(2,456)(2,339)(5,845)(6,126)
Gross loss(1,192)60(2,492)(246)
Income from grants4962941,6901,011
Research and development expenses(2,131)(2,547)(8,155)(7,338)
Administrative and selling expenses(8,916)(8,203)(25,736)(26,657)
Sublease income139404
Amortization of intangibles(117)(696)(526)(2,113)
Credit loss – customer contracts64(63)
Impairment losses(9,763)
Operating loss(11,657)(11,092)(44,641)(35,343)
Fair value change of warrant liability(134)(911)3557,248
Finance income / (expenses), net118(9)
Foreign exchange gains / (losses), net(12)(33)106(51)
Other income / (expenses), net(123)1(883)(220)
Loss before income tax(11,926)(12,035)(44,945)(28,375)
Income taxes80567(720)1,663
Net loss$ (11,846)$ (11,468)$ (45,665)$ (26,712)
Net loss per share    
Basic loss per share$ (0.20)$ (0.22)$ (0.83)$ (0.52)
Basic weighted average number of shares60,371,47351,660,13355,294,61051,465,004
Diluted loss per share$ (0.20)$ (0.22)$ (0.83)$ (0.52)
Diluted weighted average number of shares60,371,47351,660,13355,294,61051,465,004

ADN Balance Sheet

2023-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 3,661$ 32,869
Restricted cash, current2,018
Accounts receivable, net833979
Contract assets6352
Inventories13,91312,620
Prepaid expenses and Other current assets3,0302,980
Total current assets23,51849,500
Non-current assets:  
Goodwill5,742
Intangibles, net1,7896,062
Property and equipment, net24,26017,938
Right-of-use assets3,7414,055
Restricted cash, non-current750750
Other non-current assets1,0235,221
Available for sale financial asset316320
Total non-current assets31,87940,088
Total assets55,39789,588
Current liabilities:  
Trade and other payables6,1344,680
Deferred income from grants, current780801
Contract liabilities7121,019
Other current liabilities2,6684,703
Operating lease liabilities2,3402,280
Income tax payable181183
Total current liabilities12,81513,666
Non-current liabilities:  
Warrant liability99998
Long-term operating lease liabilities8,7749,802
Defined benefit obligation8972
Deferred income from grants, non-current33850
Other long-term liabilities700852
Total non-current liabilities10,00011,774
Total liabilities22,81525,440
Stockholders’ equity  
Common stock ($0.0001 par value per share; Shares authorized: 500,000,000 and 110,000,000 at September 30, 2023 and December 31, 2022, respectively; Issued and outstanding: 62,108,317 and 51,717,720 at September 30, 2023 and December 31, 2022, respectively)65
Preferred stock ($0.0001 par value per share; Shares authorized: 1,000,000 at September 30, 2023 and December 31, 2022; 0 nil issued and outstanding at September 30, 2023 and December 31, 2022)
Additional paid-in capital188,850174,509
Accumulated other comprehensive loss(2,847)(2,604)
Accumulated deficit(153,427)(107,762)
Total stockholders’ equity32,58264,148
Total liabilities and stockholders’ equity$ 55,397$ 89,588
ADN
Advent Technologies Holdings, Inc., an advanced materials and technology development company, operates in the fuel cell and hydrogen technology markets in North America, Europe, and Asia. It develops, manufactures, and assembles fuel cell systems and critical components that determine the performance of hydrogen fuel cells and other energy systems. The company offers high-temperature proton exchange membrane (HT-PEM) fuel cells, including membrane electrode assemblies, bipolar plates, and reformers, as well as provides fuel-cell stack assembly and testing services. It serves stationary power, portable power, automotive, aviation, energy storage, and sensor markets. The company is headquartered in Boston, Massachusetts.
 CEO
 WEBSITEwww.advent.energy
 EMPLOYEES175

Advent Technologies Holdings, Inc. Frequently Asked Questions


What is the ticker symbol for Advent Technologies Holdings, Inc.? What does ADN stand for in stocks?

ADN is the stock ticker symbol of Advent Technologies Holdings, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Advent Technologies Holdings, Inc. (ADN)?

As of Tue Feb 20 2024, market cap of Advent Technologies Holdings, Inc. is 10.63 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ADN stock?

You can check ADN's fair value in chart for subscribers.

What is the fair value of ADN stock?

You can check ADN's fair value in chart for subscribers. The fair value of Advent Technologies Holdings, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Advent Technologies Holdings, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ADN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Advent Technologies Holdings, Inc. a good stock to buy?

The fair value guage provides a quick view whether ADN is over valued or under valued. Whether Advent Technologies Holdings, Inc. is cheap or expensive depends on the assumptions which impact Advent Technologies Holdings, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ADN.

What is Advent Technologies Holdings, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Feb 20 2024, ADN's PE ratio (Price to Earnings) is -0.11 and Price to Sales (PS) ratio is 2. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ADN PE ratio will change depending on the future growth rate expectations of investors.